Ligand Pharmaceuticals Incorporated (LGND) — Net Asset Quality Index

Latest as of March 2026: 65.1%

Ligand Pharmaceuticals Incorporated (LGND) has a Net Asset Quality Index of 65.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.53 Billion minus total liabilities of $534.78 Million yields net assets of $997.32 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check financial resilience of Ligand Pharmaceuticals Incorporated to evaluate the company's liquid asset resilience ratio.

Quality Index

65.1%
Equity / Total Assets

Net Assets

$997.32 Million
USD

Total Assets

$1.53 Billion
USD

Total Liabilities

$534.78 Million
USD

Ligand Pharmaceuticals Incorporated Net Asset Quality Index Over Time (1994–2025)

This chart shows how Ligand Pharmaceuticals Incorporated's Net Asset Quality Index has evolved across 32 annual periods from 1994 to 2025. As of March 2026, the index stands at 65.1%, representing net assets of $997.32 Million against total assets of $1.53 Billion USD. See Ligand Pharmaceuticals Incorporated (LGND) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Annual Net Asset Quality Index for Ligand Pharmaceuticals Incorporated (1994–2025)

The table below presents the year-by-year Net Asset Quality Index for Ligand Pharmaceuticals Incorporated from 1994 to 2025, covering 32 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of Ligand Pharmaceuticals Incorporated.

Year Quality Index Net Assets (USD) Total Assets Total Liabilities Change (pp)
2025 65.2% $1.02 Billion $1.56 Billion $543.42 Million ▼ -23.0 pp
2024 88.2% $830.44 Million $941.77 Million $111.33 Million ▼ -0.9 pp
2023 89.0% $700.91 Million $787.22 Million $86.30 Million ▲ +10.7 pp
2022 78.3% $597.49 Million $762.67 Million $165.18 Million ▲ +15.1 pp
2021 63.3% $821.16 Million $1.30 Billion $476.43 Million ▲ +11.2 pp
2020 52.1% $709.52 Million $1.36 Billion $652.76 Million ▲ +0.8 pp
2019 51.3% $767.23 Million $1.49 Billion $727.68 Million ▲ +6.8 pp
2018 44.5% $560.91 Million $1.26 Billion $699.89 Million ▼ -17.9 pp
2017 62.4% $418.65 Million $671.02 Million $252.37 Million ▲ +0.7 pp
2016 61.6% $370.85 Million $601.59 Million $230.73 Million ▲ +4.6 pp
2015 57.0% $304.39 Million $533.93 Million $229.54 Million ▲ +47.6 pp
2014 9.5% $24.41 Million $258.03 Million $233.62 Million ▼ -37.9 pp
2013 47.4% $49.61 Million $104.71 Million $55.10 Million ▲ +22.0 pp
2012 25.4% $26.48 Million $104.26 Million $77.78 Million ▲ +18.3 pp
2011 7.1% $8.65 Million $122.35 Million $113.70 Million ▲ +16.3 pp
2010 -9.3% $-6.99 Million $75.56 Million $82.55 Million ▼ -12.5 pp
2009 3.3% $3.74 Million $113.70 Million $109.95 Million ▲ +9.3 pp
2008 -6.0% $-10.37 Million $171.45 Million $181.81 Million ▼ -22.8 pp
2007 16.8% $29.11 Million $173.28 Million $144.16 Million ▲ +8.4 pp
2006 8.4% $27.35 Million $326.05 Million $298.70 Million ▲ +43.5 pp
2005 -35.1% $-110.42 Million $314.62 Million $425.04 Million ▼ -12.4 pp
2004 -22.7% $-75.32 Million $332.47 Million $407.78 Million ▼ -46.1 pp
2003 23.5% $70.73 Million $301.25 Million $230.53 Million ▼ -3.9 pp
2002 27.4% $74.02 Million $270.61 Million $196.59 Million ▲ +76.6 pp
2001 -49.3% $-57.88 Million $117.47 Million $175.35 Million ▼ -0.7 pp
2000 -48.6% $-55.12 Million $113.42 Million $168.55 Million ▼ -29.6 pp
1999 -19.0% $-25.60 Million $134.60 Million $160.20 Million ▼ -11.7 pp
1998 -7.3% $-11.40 Million $156.00 Million $167.40 Million ▼ -39.2 pp
1997 31.9% $34.30 Million $107.40 Million $73.10 Million ▼ -1.9 pp
1996 33.8% $34.50 Million $102.10 Million $67.60 Million ▲ +3.8 pp
1995 30.0% $28.10 Million $93.60 Million $65.50 Million ▼ -26.3 pp
1994 56.3% $26.30 Million $46.70 Million $20.40 Million
pp = percentage points